Outcome following nivolumab treatment in patients with advanced non-small cell lung cancer and comorbid interstitial lung disease in a real-world setting.

Jean-Baptiste Assié,Christos Chouaïd,Hilario Nunes,Dorothée Reynaud,Anne-Françoise Gaudin,Valentine Grumberg,Ronan Jolivel,Baptiste Jouaneton,François-Emery Cotté,Boris Duchemann

Therapeutic advances in medical oncology（2023）

引用 1|浏览19

暂无评分

摘要

In this large cohort of aNSCLC patients with ILD, outcomes are similar to those obtained in the non-ILD population. Immunotherapy could be beneficial for these patients.

查看译文

关键词

SNDS,immunotherapy,interstitial lung disease,nivolumab,non-small cell lung cancer,survival

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要